Follow
Karina-Doris Vihta
Karina-Doris Vihta
Verified email at eng.ox.ac.uk
Title
Cited by
Cited by
Year
Effect of Delta variant on viral burden and vaccine effectiveness against new SARS-CoV-2 infections in the UK
KB Pouwels, E Pritchard, PC Matthews, N Stoesser, DW Eyre, KD Vihta, ...
Nature medicine 27 (12), 2127-2135, 2021
6212021
Impact of vaccination on new SARS-CoV-2 infections in the United Kingdom
E Pritchard, PC Matthews, N Stoesser, DW Eyre, O Gethings, KD Vihta, ...
Nature medicine 27 (8), 1370-1378, 2021
3242021
Community prevalence of SARS-CoV-2 in England from April to November, 2020: results from the ONS Coronavirus Infection Survey
KB Pouwels, T House, E Pritchard, JV Robotham, PJ Birrell, A Gelman, ...
The Lancet Public Health 6 (1), e30-e38, 2021
1822021
Trends over time in Escherichia coli bloodstream infections, urinary tract infections, and antibiotic susceptibilities in Oxfordshire, UK, 1998–2016: a study of electronic …
KD Vihta, N Stoesser, MJ Llewelyn, TP Quan, T Davies, NJ Fawcett, ...
The Lancet Infectious Diseases 18 (10), 1138-1149, 2018
1522018
Omicron-associated changes in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) symptoms in the United Kingdom
KD Vihta, KB Pouwels, TEA Peto, E Pritchard, T House, R Studley, ...
Clinical Infectious Diseases 76 (3), e133-e141, 2023
1132023
Ct threshold values, a proxy for viral load in community SARS-CoV-2 cases, demonstrate wide variation across populations and over time
AS Walker, E Pritchard, T House, JV Robotham, PJ Birrell, I Bell, JI Bell, ...
Elife 10, e64683, 2021
982021
Tracking the emergence of SARS-CoV-2 alpha variant in the United Kingdom
AS Walker, KD Vihta, O Gethings, E Pritchard, J Jones, T House, I Bell, ...
New England Journal of Medicine 385 (27), 2582-2585, 2021
722021
High Rates of Human Fecal Carriage of mcr-1–Positive Multidrug-Resistant Enterobacteriaceae Emerge in China in Association With Successful Plasmid Families
LL Zhong, HTT Phan, C Shen, KD Vihta, AE Sheppard, X Huang, KJ Zeng, ...
Clinical Infectious Diseases 66 (5), 676-685, 2018
692018
Increased infections, but not viral burden, with a new SARS-CoV-2 variant
AS Walker, KD Vihta, O Gethings, E Pritchard, J Jones, T House, I Bell, ...
MedRxiv, 2021.01. 13.21249721, 2021
662021
Impact of vaccination on SARS-CoV-2 cases in the community: a population-based study using the UK’s COVID-19 Infection Survey
E Pritchard, PC Matthews, N Stoesser, DW Eyre, O Gethings, KD Vihta, ...
medRxiv, 2021.04. 22.21255913, 2021
552021
Ten-year longitudinal molecular epidemiology study of Escherichia coli and Klebsiella species bloodstream infections in Oxfordshire, UK
S Lipworth, KD Vihta, K Chau, L Barker, S George, J Kavanagh, T Davies, ...
Genome medicine 13, 1-13, 2021
402021
Systematic review of wastewater surveillance of antimicrobial resistance in human populations
KK Chau, L Barker, EP Budgell, KD Vihta, N Sims, B Kasprzyk-Hordern, ...
Environment International 162, 107171, 2022
382022
Symptoms and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) positivity in the general population in the United Kingdom
KD Vihta, KB Pouwels, TEA Peto, E Pritchard, DW Eyre, T House, ...
Clinical Infectious Diseases 75 (1), e329-e337, 2022
342022
Viral load in community SARS-CoV-2 cases varies widely and temporally
AS Walker, E Pritchard, T House, JV Robotham, PJ Birrell, I Bell, JI Bell, ...
MedRxiv, 2020.10. 25.20219048, 2020
282020
Ten Years of Population-Level Genomic Escherichia coli and Klebsiella pneumoniae Serotype Surveillance Informs Vaccine Development for Invasive Infections
S Lipworth, KD Vihta, KK Chau, J Kavanagh, T Davies, S George, ...
Clinical Infectious Diseases 73 (12), 2276-2282, 2021
202021
Monitoring populations at increased risk for SARS-CoV-2 infection in the community using population-level demographic and behavioural surveillance
E Pritchard, J Jones, KD Vihta, N Stoesser, PC Matthews, DW Eyre, ...
The Lancet Regional Health–Europe 13, 2022
162022
Impact of vaccination on SARS-CoV-2 cases in the community: a population-based study using the UK’s COVID-19 Infection Survey. medRxiv
E Pritchard, PC Matthews, N Stoesser, DW Eyre, O Gethings, KD Vihta
Published online April 2021 (2021.04), 22.21255913, 2021
122021
Increased infections, but not viral burden, with a new SARS-CoV-2 variant. medRxiv 2021
AS Walker, KD Vihta, O Gethings, E Pritchard, J Jones, T House, I Bell, ...
Google Scholar, 0
8
Impact of Delta on viral burden and vaccine effectiveness against new SARS-CoV-2 infections in the UK. medRxiv. 2021: 2021.08. 18.21262237 v1
KB Pouwels, E Pritchard, P Matthews, NB Stoesser, DW Eyre, KD Vihta
View Article, 0
6
Molecular epidemiology and antimicrobial resistance phenotype of paediatric bloodstream infections caused by Gram-negative bacteria
S Lipworth, KD Vihta, T Davies, S Wright, M Tabirao, K Chau, A Vaughan, ...
Communications Medicine 2 (1), 101, 2022
52022
The system can't perform the operation now. Try again later.
Articles 1–20